Pacifica Partners’s Teladoc Health TDOC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$551 Hold
60
﹤0.01% 412
2026
Q1
$327 Hold
60
﹤0.01% 441
2025
Q4
$423 Hold
60
﹤0.01% 424
2025
Q3
$468 Hold
60
﹤0.01% 484
2025
Q2
$505 Hold
60
﹤0.01% 508
2025
Q1
$451 Hold
60
﹤0.01% 493
2024
Q4
$571 Hold
60
﹤0.01% 461
2024
Q3
$551 Hold
60
﹤0.01% 483
2024
Q2
$554 Hold
60
﹤0.01% 509
2024
Q1
$904 Hold
60
﹤0.01% 488
2023
Q4
$1.11K Hold
60
﹤0.01% 512
2023
Q3
$1.11K Hold
60
﹤0.01% 495
2023
Q2
$1.47K Hold
60
﹤0.01% 438
2023
Q1
$1.55K Hold
60
﹤0.01% 449
2022
Q4
$1.37K Hold
60
﹤0.01% 435
2022
Q3
$2K Hold
60
﹤0.01% 444
2022
Q2
$2K Buy
+60
New +$2.55K ﹤0.01% 452

Other funds holding TDOC

Pacifica Partners's TDOC Position: Q2 2026 in Review

Pacifica Partners held its Teladoc Health (TDOC) position steady in Q2 2026 at 60 shares worth $551. The position accounts for ﹤0.01% of the portfolio, ranked #412.

Pacifica Partners first reported a position in TDOC in Q2 2022 and has held it in 17 quarters since. The position peaked at $2K in Q3 2022. 61 funds tracked by Wall St. Rank hold TDOC as of Q2 2026.

  • Pacifica Partners held 60 shares of Teladoc Health worth $551 as of Q2 2026.
  • Pacifica Partners left its Teladoc Health share count unchanged in Q2 2026.
  • Teladoc Health made up ﹤0.01% of Pacifica Partners's portfolio in Q2 2026, its #412 holding.
  • Pacifica Partners first reported a position in Teladoc Health in Q2 2022 and has held it in 17 quarters since.
  • Pacifica Partners's Teladoc Health position peaked at $2K in Q3 2022.
  • 61 funds tracked by Wall St. Rank held Teladoc Health as of Q2 2026.

Based on Pacifica Partners's 13F filing for Q2 2026, filed 13 Jul 2026.